Success Stories: With Our Meticulous Efforts, A Chinese Assistant Scientist Secured his EB1-A Approval in the Field of Molecular Biology in just 6 days, Premium Processing Requested
On September 6th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Scientist in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Assistant Scientist
Country of Origin: China
State of Residence at the Time of Filing: Georgia
Approval Notice Date: September 6th, 2023
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
An Assistant Scientist approached the North America Immigration Law Group to file his alien of extraordinary ability (EB1-A) petition. Hailing from China, he has completed his Ph.D. in biochemistry and molecular biology and is also currently employed in the same field.
Since, a petition for the first preference category of individuals with extraordinary ability, (“EB1-A”), unlike the employment-based immigration visa under the second preference (“EB-2”) at least requires the following:
- Evidence of original contributions, usually through publication, of major significance in the foreign national’s field of science, scholastic, artistic, or athletic.
- No specific job offer/labor certification is required for a foreign person as long as he/she is entering the United States to continue work in the field in which he/she has an extraordinary ability, therefore self-petition is allowed.
- Performance in a significant role for organizations or establishments that have a distinguished reputation.
- Receipt of a higher salary or remuneration than is usual in the field.
- Other comparable evidence if the above types of evidence do not readily apply to the foreign national’s occupation.
- His research on RNA editing and functionality and gene expression and regulation in health and disease addresses some of our nation’s and the world’s most pressing issues, including improving our understanding of the genetic and molecular mechanisms underlying diseases that pose a major global public health burden like cancers to facilitate the discovery and development of novel therapeutic and diagnostic approaches for these diseases.
- His research has resulted in 12 peer-reviewed scientific articles, being cited 3,645 times in thousands of countries.
- He has conducted at least 43 reviews to date.
- Four fellow experts in the field further provided insight into the significance of his continuing research in the field.

